Lucia Celona

This profile gathers the share dealings of Lucia Celona across 2 companies, led by Bioverativ Inc. and Apellis Pharmaceuticals, Inc. Between 28 February 2017 and 10 February 2020, the trades on record add up to 15 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 12 February 2020 came the latest disclosure, a share grant in Apellis Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.